Alyftrek 10-50-125 MG tablet 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FCYH8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,040
Award facts
- Contract value 100% obligated
- $82,039.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $82,039.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for ALYFTREK 10-50-125 mg tablets (14-count packaging) on January 5, 2026, with an ultimate completion date of January 6, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. No subcontractors are identified on this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that positions multiple regional prime vendors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded November 13, 2025, has a $499,999,999 ceiling value and extends through December 31, 2036, structured with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, enabling the company to fulfill the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCYH8?
SPE2DR26FCYH8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FCYH8 worth?
The government has obligated $82,040 on SPE2DR26FCYH8.
Is contract SPE2DR26FCYH8 an order under another contract?
Yes. SPE2DR26FCYH8 is a delivery order under SPE2DR25D9153, an indefinite delivery contract.
Was contract SPE2DR26FCYH8 competed?
The extent of competition for SPE2DR26FCYH8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award